MIRM vs NKE · rev $336.1M vs P/E 35, rev $46.40B
Mirum Pharmaceuticals Inc (MIRM) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
MIRM currently screens at market cap $6.22B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the MIRM and NKE stock pages for the full models.
Not investment advice.